Company
Computomics
- AI
- Biotech
- Founded:
- 2012
- Location:
- Tübingen, Germany
- Funding:
- EUR 6.3 million · Series B · Aug 2026
Description
Computomics applies machine learning to genomic and bioinformatics data to produce trait discovery, predictive breeding values and data-management tools for agricultural and biotech researchers and breeders.
Related
Isomorphic LabsIsomorphic Labs uses machine learning to transform drug discovery by building predictive and generative AI models for designing molecules…
EvotecEvotec provides integrated drug discovery and preclinical development services, delivering CRO/CDMO research platforms, ADME‑Tox, biologics…
B2MetricB2Metric provides a predictive customer data platform with journey orchestration, AI decisioning, and AutoML tools to personalize channels…
GardinGardin measures live photosynthesis with proprietary chlorophyll-fluorescence optical sensors and streams data to the Gardin Pulse…
HealxHealx builds AI-driven drug discovery and development tools and therapies for rare disease patients, applying AI across discovery,…
GlasPort BioGlasPort Bio develops GasAbate and Compli360, a bio-digital manure management system that reduces slurry greenhouse gas emissions and…
NIBADA AnalyticsNIBADA Analytics applies data analysis, ML models, business intelligence reports, and statistical techniques to reveal value in client data…
deCODE geneticsdeCODE genetics operates a human gene-discovery engine that analyzes population-scale genomic data to identify genetic risk factors and…
NiumNium develops scalable gut-on-a-chip technology for microbiome discovery, using controlled microbial cultures, automated microfluidics, and…
Timeline
Funding Roundcomputomics.com ↗
TÜBINGEN, Germany, 18 August 2026 - Computomics GmbH has raised EUR 6.3 million in new equity in a Series B financing round led by Convent Capital Agri Food Fund, which invested EUR 5 million.